Mineral Changes in Osteoporosis: A Review

Bone mineral composition, crystallinity, and bone mineral content of osteoporotic patients are different from those of normal subjects. We review the evidence that these mineralization parameters contribute to the strength (fracture resistance) of bone and the methods that have been used to examine them. A specific example is provided from analysis of biopsies from the Multiple Outcomes in Raloxifene Evaluation trial. For the analyses, randomly selected biopsies from placebo, low-dose, and high-dose groups (n = 5 per group) obtained at time zero and 2 years after treatment were examined by infrared imaging spectroscopy. In all cases, comparable increases in mineral content were found, but there were no significant variations in mineral crystallinity.

[1]  C. Rimnac,et al.  A physical, chemical, and mechanical study of lumbar vertebrae from normal, ovariectomized, and nandrolone decanoate-treated cynomolgus monkeys (Macaca fascicularis). , 2000, Bone.

[2]  G. Daculsi,et al.  Ultrastructural Properties of Bone Mineral of Control and Tiludronate-Treated Osteoporotic Rat , 2000, Calcified Tissue International.

[3]  H Weinans,et al.  Altered tissue properties induce changes in cancellous bone architecture in aging and diseases. , 2004, Journal of biomechanics.

[4]  L. Claes,et al.  Prediction of cortical bone porosity in vitro by microcomputed tomography. , 2001, Calcified tissue international.

[5]  D. Fernández,et al.  Alendronate zwitterions bind to calcium cations arranged in columns. , 2003, Acta crystallographica. Section C, Crystal structure communications.

[6]  H. M. Kim,et al.  Phosphate Ions in Bone: Identification of a Calcium–Organic Phosphate Complex by 31P Solid-State NMR Spectroscopy at Early Stages of Mineralization , 2003, Calcified Tissue International.

[7]  M. Chance,et al.  In situ chemistry of osteoporosis revealed by synchrotron infrared microspectroscopy. , 2003, Bone.

[8]  S. Khosla,et al.  Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis. , 2002, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[9]  M. Chance,et al.  Characterization of bone mineral composition in the proximal tibia of cynomolgus monkeys: effect of ovariectomy and nandrolone decanoate treatment. , 2002, Bone.

[10]  S. Cummings,et al.  The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal Women: Results From the MORE Randomized Trial , 2000 .

[11]  J. Eisman,et al.  Limited utility of clinical indices for the prediction of symptomatic fracture risk in postmenopausal women , 2004, Osteoporosis International.

[12]  M. Grynpas,et al.  Changes in quality of bone mineral on aging and in disease. , 1988, Scanning microscopy.

[13]  D. Cheney,et al.  Characterization of the bisphosphonate recognition site on hydroxyapatite using radioligand binding techniques with [14C]citric acid , 1993, Calcified Tissue International.

[14]  C. Baud,et al.  Biophysical study of bone mineral in biopsies of osteoporotic patients before and after long-term treatment with fluoride. , 1989, Bone.

[15]  P. Marie,et al.  Effects of low doses of strontium on bone quality and quantity in rats. , 1990, Bone.

[16]  K. O’Brien.  Combined calcium and vitamin D supplementation reduces bone loss and fracture incidence in older men and women. , 2009, Nutrition reviews.

[17]  C C Glüer,et al.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. , 1999, JAMA.

[18]  R. Rizzoli,et al.  Effect of Estrogen Deficiency on Cancellous and Cortical Bone Structure and Strength of the Femoral Neck in Rats , 1997, Calcified Tissue International.

[19]  Fran Adar,et al.  Age-related changes in physicochemical properties of mineral crystals are related to impaired mechanical function of cortical bone. , 2004, Bone.

[20]  A. Boskey,et al.  Intermittent and Continuous Administration of the Bisphosphonate Ibandronate in Ovariohysterectomized Beagle Dogs: Effects on Bone Morphometry and Mineral Properties , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[21]  M. Grynpas,et al.  Changes in bone mineralization, architecture and mechanical properties due to long-term (1 year) administration of pamidronate (APD) to adult dogs , 1992, Osteoporosis International.

[22]  C. Rey,et al.  MicroRaman Spectral Study of the PO4 and CO3 Vibrational Modes in Synthetic and Biological Apatites , 1998, Calcified Tissue International.

[23]  J. Burnell,et al.  Bone matrix and mineral abnormalities in postmenopausal osteoporosis. , 1982, Metabolism: clinical and experimental.

[24]  R. Kitzes,et al.  Infrared spectroscopy and magnesium content of bone mineral in osteoporotic women. , 1981, Israel journal of medical sciences.

[25]  R. C. Reeder,et al.  Infrared microspectroscopic imaging of biomineralized tissues using a mercury-cadmium-telluride focal-plane array detector. , 1998, Cellular and molecular biology.

[26]  L. Claes,et al.  Prediction of cortical bone porosityIn Vitro by microcomputed tomography , 2007, Calcified Tissue International.

[27]  H Follet,et al.  The degree of mineralization is a determinant of bone strength: a study on human calcanei. , 2004, Bone.

[28]  B. Maldague,et al.  Treatment of the vertebral crush fracture syndrome with enteric‐coated sodium fluoride tablets and calcium supplements , 1990, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[29]  A. Boskey,et al.  Fourier transform infrared spectroscopy of the solution-mediated conversion of amorphous calcium phosphate to hydroxyapatite: New correlations between X-ray diffraction and infrared data , 2006, Calcified Tissue International.

[30]  N. Kolosova,et al.  Bone Mineralization in Senescence-Accelerated OXYS Rats , 2002, Bulletin of Experimental Biology and Medicine.

[31]  M. Wilson,et al.  Fluoride Treatment Increased Serum IGF-1, Bone Turnover, and Bone Mass, but Not Bone Strength, in Rabbits , 1997, Calcified Tissue International.

[32]  D. Rachmilewitz,et al.  Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones. , 2004, Gastroenterology.

[33]  C. Turner,et al.  The Effect of Fluoride Treatment on Bone Mineral in Rabbits , 1999, Calcified Tissue International.

[34]  J. Kanis,et al.  Diagnosis of osteoporosis and assessment of fracture risk , 2002, The Lancet.

[35]  C. Jerome.  Hormonal therapies and osteoporosis. , 2004, ILAR journal.

[36]  J A McGeough,et al.  Age-Related Changes in the Compressive Strength of Cancellous Bone. The Relative Importance of Changes in Density and Trabecular Architecture* , 1997, The Journal of bone and joint surgery. American volume.

[37]  Harry K. Genant,et al.  Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene: Results From a 3-year Randomized Clinical Trial , 2000 .

[38]  K. Pritzker,et al.  Bone mineral and osteoporosis in aging rhesus monkeys. , 1989, Puerto Rico health sciences journal.

[39]  P. Fratzl,et al.  Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women. , 2001, Bone.

[40]  P. West,et al.  Comparison of mineral quality and quantity in iliac crest biopsies from high- and low-turnover osteoporosis: an FT-IR microspectroscopic investigation , 2005, Osteoporosis International.

[41]  G. Evans,et al.  Long-Term Zoledronic Acid Treatment Increases Bone Structure and Mechanical Strength of Long Bones of Ovariectomized Adult Rats , 2003, Calcified Tissue International.

[42]  Thomas A. Corcoran,et al.  Correlations between photon absorption properties and failure load of the distal radiusin vitro , 1991, Calcified Tissue International.

[43]  J. Tuukkanen,et al.  Effects of Long-Term Administration of Clodronate on Growing Rat Bone , 2001, Calcified Tissue International.

[44]  A. Boskey,et al.  FTIR Microspectroscopic Analysis of Human Iliac Crest Biopsies from Untreated Osteoporotic Bone , 1997, Calcified Tissue International.

[45]  Georg E Fantner,et al.  High-resolution AFM imaging of intact and fractured trabecular bone. , 2004, Bone.

[46]  A. Boyde,et al.  Age changes in bone. , 1998, Gerodontology.

[47]  K. Bachus,et al.  Determining mineral content variations in bone using backscattered electron imaging. , 1997, Bone.

[48]  P. Lips,et al.  Contribution of raloxifene and calcium and vitamin D3 supplementation to the increase of the degree of mineralization of bone in postmenopausal women. , 2003, The Journal of clinical endocrinology and metabolism.

[49]  Richard Mendelsohn,et al.  Infrared analysis of bone in health and disease. , 2005, Journal of biomedical optics.

[50]  V. Coxam.  Prevention of osteopaenia by phyto-oestrogens: animal studies , 2003, British Journal of Nutrition.

[51]  A. Boskey,et al.  Infrared Analysis of the Mineral and Matrix in Bones of Osteonectin‐Null Mice and Their Wildtype Controls , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[52]  P. Meunier,et al.  The mineralization of bone tissue: a forgotten dimension in osteoporosis research , 2003, Osteoporosis International.

[53]  K. Yudoh,et al.  Telomerized presenescent osteoblasts prevent bone mass loss in vivo , 2004, Gene Therapy.

[54]  Huajian Gao,et al.  Materials become insensitive to flaws at nanoscale: Lessons from nature , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[55]  R. Recker,et al.  Distribution of Collagen Cross‐Links in Normal Human Trabecular Bone , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[56]  R Mendelsohn,et al.  Spectroscopic Characterization of Collagen Cross‐Links in Bone , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[57]  F. Branca.  Dietary phyto-oestrogens and bone health , 2003, Proceedings of the Nutrition Society.

[58]  C. Rey,et al.  The carbonate environment in bone mineral: A resolution-enhanced fourier transform infrared spectroscopy study , 1989, Calcified Tissue International.

[59]  L. Sokoll,et al.  Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. , 1991, Annals of internal medicine.

[60]  C. Rey,et al.  Resolution-enhanced fourier transform infrared spectroscopy study of the environment of phosphate ion in the early deposits of a solid phase of calcium phosphate in bone and enamel and their evolution with age: 2. Investigations in thev3 PO4 domain , 1990, Calcified Tissue International.

[61]  D. Hamerman,et al.  Alterations in mineral composition observed in osteoarthritic joints of cynomolgus monkeys. , 2004, Bone.

[62]  P. Meunier,et al.  Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[63]  T. Jämsä,et al.  The mechanical strength of bone in different rat models of experimental osteoporosis. , 1994, Bone.

[64]  S. Giannini,et al.  Bone microarchitecture as an important determinant of bone strength , 2004, Journal of endocrinological investigation.

[65]  G Boivin,et al.  Bone mineral density reflects bone mass but also the degree of mineralization of bone: therapeutic implications. , 1997, Bone.

[66]  S. Coppersmith,et al.  Spectroscopically Determined Collagen Pyr/deH-DHLNL Cross-Link Ratio and Crystallinity Indices Differ Markedly in Recombinant Congenic Mice with Divergent Calculated Bone Tissue Strength , 2003, Connective tissue research.

[67]  P. Fratzl,et al.  Mineralization of cancellous bone after alendronate and sodium fluoride treatment: a quantitative backscattered electron imaging study on minipig ribs. , 1997, Bone.

[68]  L. Lanyon,et al.  Is estrogen receptor alpha key to controlling bones' resistance to fracture? , 2004, The Journal of endocrinology.

[69]  C. Rey,et al.  The effect of fluoride treatment on bone mineral crystals in the rat. , 1992, Bone.

[70]  Z. Schwartz,et al.  Oophorectomy-Induced Osteopenia in Rats in Relation to Age and Time Postoophorectomy , 2000, Cells Tissues Organs.

[71]  P. Douglas,et al.  Treatment with growth hormone and IGF‐I in growing rats increases bone mineral content but not bone mineral density , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[72]  V. Coxam,et al.  Daidzein is more efficient than genistein in preventing ovariectomy-induced bone loss in rats. , 2000, The Journal of nutrition.

[73]  A. Bailey,et al.  Biochemical changes in the collagen of human osteoporotic bone matrix. , 1993, Connective tissue research.

[74]  J. Schwartz,et al.  Influence of bone resorption on the mobilization of lead from bone among middle-aged and elderly men: the Normative Aging Study. , 2001, Environmental health perspectives.

[75]  P. Meunier,et al.  Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. , 2000, Bone.

[76]  R. Heaney,et al.  Co-dependence of calcium and phosphorus for growth and bone development under conditions of varying deficiency. , 2003, Bone.

[77]  M. Kassem,et al.  Effect of Hormone Replacement Therapy on Bone Quality in Early Postmenopausal Women , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[78]  Y. Bae,et al.  Bone-Protecting Effect of Safflower Seeds in Ovariectomized Rats , 2002, Calcified Tissue International.

[79]  F Melsen,et al.  Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis. , 2002, Bone.

[80]  H. Oxlund,et al.  Qualitative alterations of cortical bone in female rats after long-term administration of growth hormone and glucocorticoid. , 1996, Bone.

[81]  R. Eastell,et al.  The value of biochemical markers of bone turnover in osteoporosis. , 1997, The Journal of rheumatology.

[82]  M. Morris,et al.  Application of vibrational spectroscopy to the study of mineralized tissues (review). , 2000, Journal of biomedical optics.

[83]  A. Boskey,et al.  Overexpression of IGF-Binding Protein 5 Alters Mineral and Matrix Properties in Mouse Femora: An Infrared Imaging Study , 2005, Calcified Tissue International.

[84]  J. Jeffery,et al.  Age-related changes in the orientation and particle size of the mineral phase in human femoral cortical bone , 2006, Calcified Tissue International.

[85]  K. Miyazaki,et al.  Thermal analysis of bones from ovariectomized rats. , 1998, Journal of biomedical materials research.

[86]  S. Wallach,et al.  Effects of calcitonin on animal and in vitro models of skeletal metabolism. , 1999, Bone.

[87]  Michael D Morris,et al.  Mineralization of Developing Mouse Calvaria as Revealed by Raman Microspectroscopy , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[88]  D. Burr,et al.  Bone Mineral and Collagen Quality in Humeri of Ovariectomized Cynomolgus Monkeys Given rhPTH(1–34) for 18 Months , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[89]  J. Williamson,et al.  Managing the menopause: British Menopause Society Council consensus statement on hormone replacement therapy , 2003, The journal of the British Menopause Society.

[90]  G. Evans,et al.  Loss of vertebral bone and mechanical strength in estrogen-deficient rats is prevented by long-term administration of zoledronic acid , 2004, Osteoporosis International.

[91]  J. Freudenstein,et al.  Effects of an isopropanolic extract of Cimicifuga racemosa on urinary crosslinks and other parameters of bone quality in an ovariectomized rat model of osteoporosis , 2003, Journal of Bone and Mineral Metabolism.

[92]  S. Cummings,et al.  The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation. , 1999, JAMA.

[93]  A. Parfitt,et al.  What is bone mineralization? , 2003, The Journal of clinical endocrinology and metabolism.

[94]  E. Wagner,et al.  Normal mineralization and nanostructure of sclerotic bone in mice overexpressing Fra-1. , 2004, Bone.

[95]  P. Meunier,et al.  Methodological considerations in measurement of bone mineral content , 2003, Osteoporosis International.

[96]  L H Kidder,et al.  Applications of Fourier Transform Infrared Imaging Microscopy in Neurotoxicity , 1997, Annals of the New York Academy of Sciences.

[97]  M. Rogers,et al.  Bisphosphonates: from the laboratory to the clinic and back again. , 1999, Bone.

[98]  J. Ackerman,et al.  Detection of Hydroxyl Ions in Bone Mineral by Solid-State NMR Spectroscopy , 2003, Science.

[99]  P. Fratzl,et al.  Abnormal bone mineralization after fluoride treatment in osteoporosis: A small‐angle x‐ray‐scattering study , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[100]  Richard Mendelsohn,et al.  Chemical Structure-Based Three-Dimensional Reconstruction of Human Cortical Bone from Two-Dimensional Infrared Images , 2002 .

[101]  A. Boskey,et al.  Fourier Transform Infrared Microscopic Imaging: Effects of Estrogen and Estrogen Deficiency on Fracture Healing in Rat Femurs , 2004, Applied spectroscopy.

[102]  S. Komatsubara,et al.  Suppressed Bone Turnover by Long‐Term Bisphosphonate Treatment Accumulates Microdamage but Maintains Intrinsic Material Properties in Cortical Bone of Dog Rib , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[103]  C. Rey,et al.  Characterization of the trabecular rat bone mineral: effect of ovariectomy and bisphosphonate treatment. , 2000, Bone.

[104]  M. Ettinger,et al.  Aging bone and osteoporosis: strategies for preventing fractures in the elderly. , 2003, Archives of internal medicine.

[105]  R Mendelsohn,et al.  Infrared spectroscopy, microscopy, and microscopic imaging of mineralizing tissues: spectra-structure correlations from human iliac crest biopsies. , 1999, Journal of biomedical optics.

[106]  P. Geusens,et al.  The aged male rat as a model for human osteoporosis: Evaluation by nondestructive measurements and biomechanical testing , 1993, Calcified Tissue International.

[107]  C. Turner,et al.  Three-dimensional Modeling of the Effects of Parathyroid Hormone on Bone Distribution in Lumbar Vertebrae of Ovariectomized Cynomolgus Macaques , 2000, Osteoporosis International.

[108]  P Bouter,et al.  Micro-Raman Line Broadening in Synthetic Carbonated Hydroxyapatite , 1986, Journal of dental research.

[109]  Comparison of the compression strength of human vertebral bodies with the mass and density of apatite: a study by 31P NMR spectroscopy. , 1988, Clinical chemistry.

[110]  A. Boskey,et al.  Bone Fragility and Collagen Cross‐Links , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[111]  Charles A Cefalu,et al.  Is bone mineral density predictive of fracture risk reduction? , 2004, Current medical research and opinion.

[112]  I G Turner,et al.  The spatial arrangement of bone mineral as revealed by ion bombardment. , 1981, Biomaterials.

[113]  A. Boskey,et al.  Optimal Methods for Processing Mineralized Tissues for Fourier Transform Infrared Microspectroscopy , 2002, Calcified Tissue International.

[114]  F. Eckstein,et al.  Can geometry-based parameters from pQCT and material parameters from quantitative ultrasound (QUS) improve the prediction of radial bone strength over that by bone mass (DXA)? , 2004, Osteoporosis International.

[115]  S. Omer,et al.  Hormone replacement therapy in postmenopausal women. , 2004, American journal of surgery.

[116]  J. Currey,et al.  Effects of differences in mineralization on the mechanical properties of bone. , 1984, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[117]  M. Anthony,et al.  Soy phytoestrogens do not prevent bone loss in postmenopausal monkeys. , 2003, The Journal of clinical endocrinology and metabolism.

[118]  J. Currey.  The many adaptations of bone. , 2003, Journal of biomechanics.

[119]  A. Boskey,et al.  Calcitonin Alters Bone Quality in Beagle Dogs , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[120]  S. Goldstein,et al.  Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice , 1998, Nature Genetics.

[121]  A. Boyde,et al.  Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs. , 2003, Bone.

[122]  W. Laughlin,et al.  Comparison of bone apatite in osteoporotic and normal Eskimos , 1983, Calcified Tissue International.

[123]  Georges Boivin,et al.  Infrared imaging of calcified tissue in bone biopsies from adults with osteomalacia. , 2005, Bone.

[124]  M. Glimcher,et al.  Size and Shape of Mineralites in Young Bovine Bone Measured by Atomic Force Microscopy , 2003, Calcified Tissue International.

[125]  M. Adams,et al.  Histomorphometric and mineral density fractionation studies of lumbar vertebrae of intact and ovariectomized (OVX) monkeys. , 1994, Bone and mineral.

[126]  B. L. Riggs,et al.  Incidence of hip fractures in osteoporotic women treated with sodium fluoride , 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.